ICT Module III
Upon completion of the module, the participant will:
- Review current concepts in immunology
- Know the immunological tests that are currently available
- Review the medical literature on immunosuppression and cancer
- Look at the multifactorial basis of immunodeficiency in cancer patients
- Understand effector cell numbers and function
- Know immunoregulatory cells and immunomodulatory factors
- Look at immunosuppression and tumor cell burden
- Understand the function of T-lymphocytes, T-helper cells, T-suppressor cells, T-cytotoxic cells, B lymphocytes, monocytes, macrophages, natural killer cells, and lymphokine-activated killer cells
- Evaluate sold tumors in the light of immunological function
- Understand hematopoietic malignancies in the light of immunology
- Evaluate radiation-induced immunosuppression
- Comprehend chemotherapy-induced immunosuppression
- Look at the immune status of patients in clinical remission
- Lean treatments of caner-associated immunodeficiency
- Know biological response modifiers with immunorestorative properties
- Understand the chemical properties of thymic hormones
- Learn treatment of radiotherapy-induced immunosuppression
- Learn therapies for chemotherapy-induced immunosuppression
- Learn about cancer vaccines
- Understand the cytokine sources and their effects related to the growth and treatment of cancer
- Have a working knowledge of all of the interleukins
- Understand tumor necrosis factor alpha and its effects on inflammation, immune regulation, apoptosis, and endothelial damage
- Understand interferon therapy for specific cancers
- Understand the mode of action of interferons in cancer treatment
- Learn about monoclonal antibody therapy
- Study immunotoxins
- Learn new testing methods for immunological markers
- Train in granulocyte colony-stimulating factor therapies
- Understand the clinical implications of granulocyte-macrophage colony-stimulating factor therapies and immunomodulation
- Review heat shock proteins as regulators of the immune response
- Understand the role of gene rearrangement in the tumor response
- Look at how tumors avoid the immune response
Schedule:
| Low Dose Metronomic Chemotherapy | Mark Rosenberg, MD | 1 hr |
| Organs of the Immune System | Dwight McKee, MD | 1 hr |
| Introduction of Immunology: The Immune System | Dwight McKee, MD | 1 hr |
| Introduction to Tumor Immunology | Dwight McKee, MD | 1 hr |
| Advanced Tumor Immunotherapy | Dwight KcKee, MD | 1 hr |
| ImmunoCompetence/ ImmuneDeficiency and Clinical Course | Donald Braun, PhD | 1 hr |
| Immune Response to Cancer in Different Anatomic Sites | Donald Braun, PhD | 1 hr |
| Cytokine-Based Immune Therapies | Donald Braun, PhD | 1 hr |
| Adoptive Cellular Immunotherapy of Cancer | Donald Braun, PhD | 1 hr |
| Monoclonal Ab Therapy to Cancer | Donald Braun, PhD | 1 hr |
| GcMAF | Dwight KcKee, MD | 1 hr |
| Stress, Immune System and Cancer | Dwight McKee, MD | 1 hr |
| Inflammation, Gut Integrity, Diet and Immune Functions | Dwight McKee, MD | 1 hr |
| Mechanisms of Immune Suppression By Tumor Cells | Dwight McKee, MD | 1 hr |
| Cancer Vaccination Strategies: Clinical Results | Donald Braun, PhD | 2 hr |
| Obesity, Insulin and Cancer: The Role of the Insulin-IGF Pathway on the Origins and the Outcome of Cancer | Barry Boyd, MD | 2 hr |
| Mechanisms for Collaboration Between Conventional Therapy and AntiTumor Immunity | Donald Braun, PhD | 1 hr |
| Effects of Naturopathic/Nutritional Supplements on Immune Response to Cancer | Donald Braun, PhD | 1 hr |
| Integrative Approach to Prostate Cancer | Pyuish Bhatnagar, MD | 1 hr |
| Integrative Approach to Lung Cancer | Pyuish Bhatnagar, MD | 1 hr |
| Epigenetic Regulation of DNA Repair Pathways and Their Modulation to Reverse Chemotherapy Resistance in Melanoma | Hussein Tawbi, MD | 2 hr |
